Correlation Between Oncorus and Quoin Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncorus and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Oncorus and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Quoin Pharmaceuticals.

Diversification Opportunities for Oncorus and Quoin Pharmaceuticals

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Oncorus and Quoin is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Oncorus i.e., Oncorus and Quoin Pharmaceuticals go up and down completely randomly.

Pair Corralation between Oncorus and Quoin Pharmaceuticals

Given the investment horizon of 90 days Oncorus is expected to under-perform the Quoin Pharmaceuticals. In addition to that, Oncorus is 4.21 times more volatile than Quoin Pharmaceuticals Ltd. It trades about -0.15 of its total potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.05 per unit of volatility. If you would invest  581.00  in Quoin Pharmaceuticals Ltd on August 31, 2024 and sell it today you would lose (521.00) from holding Quoin Pharmaceuticals Ltd or give up 89.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy2.95%
ValuesDaily Returns

Oncorus  vs.  Quoin Pharmaceuticals Ltd

 Performance 
       Timeline  
Oncorus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncorus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Quoin Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Oncorus and Quoin Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncorus and Quoin Pharmaceuticals

The main advantage of trading using opposite Oncorus and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.
The idea behind Oncorus and Quoin Pharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios